Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gam-COVID-Vac (Gamaleya Center)
- Development stage
- Unknown
- Lead developer
- Gamaleya Center
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**Gam-COVID-Vac** is a two-component heterologous recombinant adenoviral-vector vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology for prevention of COVID-19. Component I uses recombinant adenovirus type 26 and Component II uses recombinant adenovirus type 5; both vectors encode the full-length SARS-CoV-2 spike glycoprotein. Intramuscular prime-boost administration induces humoral and cellular immune responses directed against spike, supporting protection against SARS-CoV-2 infection and COVID-19. The vaccine is marketed as Sputnik V and was registered by the Russian Ministry of Health in August 2020; an interim Phase 3 analysis reported 91.6% efficacy against symptomatic COVID-19. ([thelancet.com](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2821%2900234-8/fulltext))
- Brand names
- Sputnik V
- Other names
- GamCovidVac
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on Gam-COVID-Vac (Gamaleya Center).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gam-COVID-Vac (Gamaleya Center).